Dyne Therapeutics Inc

NASDAQ: DYN
$23.65
-$1.17 (-4.7%)
Closing price April 18, 2024
Dyne Therapeutics Inc is a pioneering biotech firm based in Waltham, Massachusetts, dedicated to developing innovative treatments for a range of genetically driven muscle diseases. With a focus on conditions like myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, the company leverages its proprietary FORCE platform to create therapeutics aimed at modifying the course of these diseases. Founded in 2017, Dyne Therapeutics is at the forefront of addressing unmet needs in muscle disease treatment.
US equities opened higher this morning following the report on a US non-farm payroll gain of 227,000 jobs (more coverage here). In Europe, the Greek debt swap deal went off smoothly, but the...
Equities started the day with a solid move up, but lost momentum after about half an hour. The downward move lasted into the late morning, at which time stocks started a fitful climb back up. There...
It has happened before, but it is rare.  Very rare.  A bankruptcy that is good for shareholders. Dynegy Inc. (NYSE: DYN) is seeing a sharp rise in its common stock after some of the financial...
Olympus says it concealed losses for decades. (Reuters)Italy’s sovereign debt interest rates rise sharply. (Reuters)Toyota’s (NYSE: TM) profits fall and it withdraws its full-year forecast....
Debt and credit rating agencies made a number of changes yesterday, led by the downgrade of Italian sovereign debt by Standard & Poor’s. The agencies also issued changes to debt ratings for the...
Investor Carl Icahn has agreed to sell his stake in Lions Gate Entertainment Corp. (NYSE: LGF) at a discount to yesterday’s closing price of $7.52. That announcement came shortly after Icahn also...
There are going to be more than just several key equity issues to watch in the week ahead.  24/7 Wall St. has compiled this weekend’s previews of non-earnings events to watch this coming week in...
We have already seen (some) of the position changes of Warren Buffett, but the old guy wouldn’t share many ‘confidential positions’ so we are whale watching in other ponds.  We wanted to take...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning.Arcelor Mittal (NYSE: MT) Raised to Buy at Goldman Sachs....
Electric energy provider Dynegy (NYSE: DYN) has been through a great deal recently. It threatened to file Chapter 11. The firm said it might not be able to refinance a credit facility. The...
BP (NYSE: BP) stayed at the top of the list of companies receiving the most negative news after skepticism about its CEO’s apology about Deepwater Horizon. Dynegy (NYSE: DYN) threatened a Chapter...
When Dynegy Inc. (NYSE: DYN) reported earnings, or rather, losses, yesterday, the company also included the dreaded “going concern” statement telling investors that unless the company could...
After failing to pull the trigger on two buyout offers, Dynegy Corp. (NYSE: DYN) stated in its 10-K filing yesterday that it still has plenty of problems:“Our accompanying consolidated financial...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning.Cheniere Energy Partners LP. (AMEX: CQP) Raised to Hold at...
Earnings season has mostly come to a close but we still have many companies trickling out earnings which could easily move the needle on shares.  This coming week we will be watching out for...